• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BACE过表达时Glu11位点的切割及N端截短的Aβ生成

Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.

作者信息

Liu Kangning, Doms Robert W, Lee Virginia M-Y

机构信息

The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

出版信息

Biochemistry. 2002 Mar 5;41(9):3128-36. doi: 10.1021/bi015800g.

DOI:10.1021/bi015800g
PMID:11863452
Abstract

Amyloid beta peptides (A beta) are generated by the proteolytic processing of the amyloid beta precursor protein (APP). The newly identified beta-site APP-cleaving enzyme (BACE) cleaves APP at Asp1 as well as between Tyr10 and Glu11 of A beta, producing C-terminal fragments (CTFs) C99 and C89, respectively. Subsequent cleavage by gamma-secretase gives rise to A beta 1-40/42 and A beta 11-40/42. Although both full-length and A beta peptides truncated at residue 11 have been identified in amyloid plaques in the AD brain, the relative proportion of these two cleavage products produced by BACE and secreted into the medium by cultured cells is unknown. Using cell lines stably overexpressing BACE, we found that A beta 11-40 and A beta 11-42 are major A beta cleavage products generated by BACE. We further showed that BACE utilizes both full-length APP as well as C99 as substrates for the production of C89, and that A beta 11-40/42 can be generated by sequential cleavage of single APP molecules by BACE and gamma-secretase. Taken together, the abundance of A beta 11-40/42 produced by BACE suggests that their roles in AD pathogenesis may be underestimated.

摘要

淀粉样β肽(Aβ)由淀粉样β前体蛋白(APP)的蛋白水解加工产生。新发现的β位点APP裂解酶(BACE)在天冬氨酸1处以及Aβ的酪氨酸10和谷氨酸11之间裂解APP,分别产生C末端片段(CTF)C99和C89。随后γ-分泌酶的裂解产生Aβ1-40/42和Aβ11-40/42。尽管在AD大脑的淀粉样斑块中已鉴定出全长和在残基11处截短的Aβ肽,但BACE产生并由培养细胞分泌到培养基中的这两种裂解产物的相对比例尚不清楚。使用稳定过表达BACE的细胞系,我们发现Aβ11-40和Aβ11-42是BACE产生的主要Aβ裂解产物。我们进一步表明,BACE利用全长APP以及C99作为产生C89的底物,并且Aβ11-40/42可以通过BACE和γ-分泌酶对单个APP分子的顺序裂解产生。综上所述,BACE产生的Aβ11-40/42的丰度表明它们在AD发病机制中的作用可能被低估了。

相似文献

1
Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.BACE过表达时Glu11位点的切割及N端截短的Aβ生成
Biochemistry. 2002 Mar 5;41(9):3128-36. doi: 10.1021/bi015800g.
2
Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.淀粉样β蛋白(Aβ)Glu11 是β-位淀粉样前体蛋白裂解酶 1(BACE1)的主要β-分泌酶位点,将裂解位点转移到 Aβ Asp1 有助于阿尔茨海默病的发病机制。
Eur J Neurosci. 2013 Jun;37(12):1962-9. doi: 10.1111/ejn.12235.
3
Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.嗜铬细胞调节性分泌囊泡中的β-淀粉样肽:嗜铬囊泡中β-分泌酶活性不同途径存在多种半胱氨酸蛋白水解活性的证据。
J Neurochem. 2002 Apr;81(2):237-56. doi: 10.1046/j.1471-4159.2002.00794.x.
4
Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid.人类β-分泌酶在小鼠大脑中的表达增加了β-淀粉样蛋白的稳态水平。
J Neurochem. 2002 Mar;80(5):799-806. doi: 10.1046/j.0022-3042.2002.00770.x.
5
Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.淀粉样β肽中氨基酸残基34处的β-分泌酶切割依赖于γ-分泌酶活性。
J Biol Chem. 2003 Jun 6;278(23):21286-94. doi: 10.1074/jbc.M209859200. Epub 2003 Mar 27.
6
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.β-分泌酶基因敲除小鼠尽管大脑中缺乏主要的β-分泌酶活性,但仍健康:对阿尔茨海默病治疗的启示。
Hum Mol Genet. 2001 Jun 1;10(12):1317-24. doi: 10.1093/hmg/10.12.1317.
7
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.跨膜天冬氨酸蛋白酶BACE对阿尔茨海默病淀粉样前体蛋白的β-分泌酶切割。
Science. 1999 Oct 22;286(5440):735-41. doi: 10.1126/science.286.5440.735.
8
Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.淀粉样前体蛋白的区室化限制β-淀粉样蛋白的产生:基于β-分泌酶区室化的治疗靶点。
J Mol Neurosci. 2004;24(1):137-43. doi: 10.1385/JMN:24:1:137.
9
Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage.格列卫将淀粉样前体蛋白(APP)的加工过程从β-切割转变为非淀粉样生成切割。
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):1389-1394. doi: 10.1073/pnas.1620963114. Epub 2017 Jan 23.
10
Degradation of BACE by the ubiquitin-proteasome pathway.β-分泌酶(BACE)通过泛素-蛋白酶体途径降解。
FASEB J. 2004 Oct;18(13):1571-3. doi: 10.1096/fj.04-1994fje. Epub 2004 Aug 2.

引用本文的文献

1
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
2
Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.在阿尔茨海默病受累神经元中,淀粉样前体蛋白水解途径中β淀粉样蛋白的产生停止或受到严重抑制:对“显而易见”的观点提出质疑。
Genes (Basel). 2025 Jan 2;16(1):46. doi: 10.3390/genes16010046.
3
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.精髓协同作用:同时给予综合应激反应抑制剂和 BACE1 和/或 BACE2 激活剂,作为阿尔茨海默病的最佳治疗策略。
Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913.
4
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.
5
Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (Aβ) by Its Targeted Degradation via Augmentation of Intra-Aβ-Cleaving Activities of BACE1 and/or BACE2.用于治疗和预防阿尔茨海默病和与衰老相关的认知能力下降的下一代治疗策略:通过增强 BACE1 和/或 BACE2 的 intra-Aβ 裂解活性,靶向性地使细胞内 Aβ (Aβ) 短暂、一次性耗尽。
Int J Mol Sci. 2023 Dec 18;24(24):17586. doi: 10.3390/ijms242417586.
6
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.阿尔茨海默病和与衰老相关的认知能力下降的淀粉样蛋白级联假说 2.0:从分子基础到有效治疗。
Int J Mol Sci. 2023 Jul 31;24(15):12246. doi: 10.3390/ijms241512246.
7
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept.淀粉样蛋白级联假说2.0:概念的推广
J Alzheimers Dis Rep. 2023 Jan 19;7(1):21-35. doi: 10.3233/ADR-220079. eCollection 2023.
8
Discovery of Compounds That Selectively Repress the Amyloidogenic Processing of the Amyloid Precursor Protein: Design, Synthesis and Pharmacological Evaluation of Diphenylpyrazoles.发现选择性抑制淀粉样前体蛋白淀粉样生成处理的化合物:二苯吡唑的设计、合成和药理评价。
Int J Mol Sci. 2022 Oct 28;23(21):13111. doi: 10.3390/ijms232113111.
9
The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer's Disease and for Its Potential Cure at Symptomatic Stages.淀粉样蛋白级联假说2.0:关于预防阿尔茨海默病及在症状阶段实现潜在治愈的一次性终身治疗的可能性。
J Alzheimers Dis Rep. 2022 Jul 11;6(1):369-399. doi: 10.3233/ADR-220031. eCollection 2022.
10
A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome.阿尔茨海默病的当前哺乳动物模型综述及需克服的挑战
Int J Mol Sci. 2021 Dec 6;22(23):13168. doi: 10.3390/ijms222313168.